LDL Cholesterol Rises With BMI Only in Lean Individuals: Cross-sectional US and Spanish Representative Data

被引:34
作者
Laclaustra, Martin [1 ,2 ,3 ]
Lopez-Garcia, Esther [3 ,4 ]
Civeira, Fernando [1 ,2 ]
Garcia-Esquinas, Esther [3 ]
Graciani, Auxiliadora [3 ]
Guallar-Castillon, Pilar [3 ,4 ]
Banegas, Jose R. [3 ]
Rodriguez-Artalejo, Fernando [3 ,4 ]
机构
[1] Univ Zaragoza, Hosp Univ Miguel Servet, Ctr Invest Biomed Red Enfermedades Cardiovasc CIB, Zaragoza, Spain
[2] Univ Zaragoza, Hosp Univ Miguel Servet, Inst Invest Sanitaria Aragon IIS Aragon, Translat Res Unit, Zaragoza, Spain
[3] Univ Autonoma Madrid, Inst Invest Hosp La Paz IDIPAZ, Ctr Invest Biomed Red Epidemiol & Salud Publ CIBE, Dept Prevent Med & Publ Hlth,Sch Med, Madrid, Spain
[4] UAM, CSIC, Ctr Excelencia Int, Inst Madrileno Estudios Avanzados Alimentac IMDEA, Madrid, Spain
基金
欧盟地平线“2020”;
关键词
BODY-MASS INDEX; DENSITY-LIPOPROTEIN CHOLESTEROL; DISEASE COLLABORATIVE ANALYSIS; CORONARY-HEART-DISEASE; OBESITY; DETERMINANTS; OVERWEIGHT; ADIPOSITY; WEIGHT;
D O I
10.2337/dc18-0372
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVEElevated LDL cholesterol (LDLc) is not strongly associated with obesity or metabolic syndrome (MS), but this relationship repeatedly has been examined assuming a linear association. This study aimed to assess the dose-response relationship between body mass index (BMI) or waist circumference (WC) and LDLc and to evaluate its link to metabolic impairment.RESEARCH DESIGN AND METHODSParticipants in the continuous National Health and Nutrition Examination Survey (NHANES, 1999-2010) (n = 12,383) and the Study on Nutrition and Cardiovascular Risk (ENRICA, 2008-2010) (n = 11,765), representative samples of U.S. and Spanish noninstitutionalized populations, were cross-sectionally investigated. LDLc was modeled with age- and sex-adjusted regressions, with BMI and/or WC as explanatory variables included in models as two-segment linear and natural cubic splines.RESULTSIn NHANES and ENRICA, slopes of the BMI-LDLc association changed (P < 0.001) at BMI 27.1 and 26.5 kg/m(2), respectively, forming an inverted U shape. Below these BMI inflection points, LDLc rose 2.30 and 2.41 mg/dL per kg/m(2) (both P < 0.001). However, above said points, LDLc declined -0.37 and -0.38 mg/dL per kg/m(2) (both P < 0.001). The WC-LDLc relationship was similar to the BMI-LDLc relationship. Accumulation of MS traits was associated with a weakening of the positive BMI-LDLc association among lean participants (below the BMI inflection point). Aging shifted the inflection point of the BMI-LDLc relationship to lower BMI values.CONCLUSIONSThe BMI- and WC-LDLc relationships have inverted U shapes. Diminishing associations between BMI and LDLc might indicate metabolic impairment as a result of aging or other metabolic diseases. In lean individuals, small weight losses might help to lower LDLc for cardiovascular prevention.
引用
收藏
页码:2195 / 2201
页数:7
相关论文
共 33 条
[21]   Metabolic mediators of the effects of body-mass index, overweight, and obesity on coronary heart disease and stroke: a pooled analysis of 97 prospective cohorts with 1.8 million participants [J].
Lu, Yuan ;
Hajifathalian, Kaveh ;
Ezzati, Majid ;
Woodward, Mark ;
Rimm, Eric B. ;
Danaei, Goodarz .
LANCET, 2014, 383 (9921) :970-983
[22]   Positive Relationship between Serum Low-Density Lipoprotein Cholesterol Levels and Visceral Fat in a Chinese Nondiabetic Population [J].
Luo, Yuqi ;
Ma, Xiaojing ;
Shen, Yun ;
Hao, Yaping ;
Hu, Yaqin ;
Xiao, Yunfeng ;
Bao, Yuqian ;
Jia, Weiping .
PLOS ONE, 2014, 9 (11)
[23]  
Maki KC, 1997, J AM COLL NUTR, V16, P578
[24]   Prevalence of insulin resistance and associated cardiovascular disease risk factors among normal weight, overweight, and obese individuals [J].
McLaughlin, T ;
Allison, G ;
Abbasi, F ;
Lamendola, C ;
Reaven, G .
METABOLISM-CLINICAL AND EXPERIMENTAL, 2004, 53 (04) :495-499
[25]   Rationale and Methods of the Study on Nutrition and Cardiovascular Risk in Spain (ENRICA) [J].
Rodriguez-Artalejo, Fernando ;
Graciani, Auxiliadora ;
Guallar-Castillon, Pilar ;
Leon-Munoz, Luz M. ;
Clemencia Zuluaga, M. ;
Lopez-Garcia, Esther ;
Luis Gutierrez-Fisac, Juan ;
Taboada, Jose M. ;
Teresa Aguilera, M. ;
Regidor, Enrique ;
Villar-Alvarez, Fernando ;
Banegas, Jose R. .
REVISTA ESPANOLA DE CARDIOLOGIA, 2011, 64 (10) :876-882
[26]  
Sarwar N, 2010, LANCET, V375, P1634, DOI 10.1016/S0140-6736(10)60545-4
[27]   Harmonizing the Metabolic Syndrome A Joint Interim Statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity [J].
Alberti, K. G. M. M. ;
Eckel, Robert H. ;
Grundy, Scott M. ;
Zimmet, Paul Z. ;
Cleeman, James I. ;
Donato, Karen A. ;
Fruchart, Jean-Charles ;
James, W. Philip T. ;
Loria, Catherine M. ;
Smith, Sidney C., Jr. .
CIRCULATION, 2009, 120 (16) :1640-1645
[28]   HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials [J].
Swerdlow, Daniel I. ;
Preiss, David ;
Kuchenbaecker, Karoline B. ;
Holmes, Michael V. ;
Engmann, Jorgen E. L. ;
Shah, Tina ;
Sofat, Reecha ;
Stender, Stefan ;
Johnson, Paul C. D. ;
Scott, Robert A. ;
Leusink, Maarten ;
Verweij, Niek ;
Sharp, Stephen J. ;
Guo, Yiran ;
Giambartolomei, Claudia ;
Chung, Christina ;
Peasey, Anne ;
Amuzu, Antoinette ;
Li, Kawah ;
Palmen, Jutta ;
Howard, Philip ;
Cooper, Jackie A. ;
Drenos, Fotios ;
Li, Yun R. ;
Lowe, Gordon ;
Gallacher, John ;
Stewart, Marlene C. W. ;
Tzoulaki, Ioanna ;
Buxbaum, Sarah G. ;
Daphne, L. van der A. ;
Forouhi, Nita G. ;
Onland-Moret, N. Charlotte ;
van der Schouw, Yvonne T. ;
Schnabel, Renate B. ;
Hubacek, Jaroslav A. ;
Kubinova, Ruzena ;
Baceviciene, Migle ;
Tamosiunas, Abdonas ;
Pajak, Andrzej ;
Topor-Madry, Roman ;
Stepaniak, Urszula ;
Malyutina, Sofi A. ;
Baldassarre, Damiano ;
Sennblad, Bengt ;
Tremoli, Elena ;
de Faire, Ulf ;
Veglia, Fabrizio ;
Ford, Ian ;
Jukema, J. Wouter ;
Westendorp, Rudi G. J. .
LANCET, 2015, 385 (9965) :351-361
[29]   Abnormal hepatic apolipoprotein B metabolism in type 2 diabetes [J].
Verges, Bruno .
ATHEROSCLEROSIS, 2010, 211 (02) :353-360
[30]   Body-mass index and cause-specific mortality in 900 000 adults: collaborative analyses of 57 prospective studies [J].
Whitlock, Gary ;
Lewington, Sarah ;
Sherliker, Paul ;
Clarke, Robert ;
Emberson, Jonathan ;
Halsey, Jim ;
Qizilbash, Nawab ;
Collins, Rory ;
Peto, Richard ;
Lewington, S. ;
MacMahon, S. ;
Peto, R. ;
Aromaa, A. ;
Baigent, C. ;
Carstensen, J. ;
Chen, Z. ;
Clarke, R. ;
Collins, R. ;
Duffy, S. ;
Kromhout, D. ;
Neaton, J. ;
Qizilbash, N. ;
Rodgers, A. ;
Tominaga, S. ;
Toernberg, S. ;
Tunstall-Pedoe, H. ;
Whitlock, G. ;
Chambless, L. ;
De Backer, G. ;
De Bacquer, D. ;
Kornitzer, M. ;
Whincup, P. ;
Wannamethee, S. G. ;
Morris, R. ;
Wald, N. ;
Morris, J. ;
Law, M. ;
Knuiman, M. ;
Bartholomew, H. ;
Smith, G. Davey ;
Sweetnam, P. ;
Elwood, P. ;
Yarnell, J. ;
Kronmal, R. ;
Kromhout, D. ;
Sutherland, S. ;
Keil, J. ;
Jensen, G. ;
Schnohr, P. ;
Hames, C. .
LANCET, 2009, 373 (9669) :1083-1096